These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8814671)

  • 1. [Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications].
    Polónia J
    Rev Port Cardiol; 1996 Apr; 15(4):281-92. PubMed ID: 8814671
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effect of drugs: statistical distribution of the trough-to-peak ratio.
    Chi VX; Chau NP
    Biometrics; 1996 Mar; 52(1):286-90. PubMed ID: 8934597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How relevant is the trough-to peak ratio?].
    Ferrari P
    Schweiz Med Wochenschr; 2000 Mar; 130(9):329-35. PubMed ID: 10746273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
    van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
    Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of through:peak ratio and the assessment of antihypertensive drug action.
    Elliott HL
    Isr J Med Sci; 1996 Oct; 32(10):798-9. PubMed ID: 8950239
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].
    Leonetti G; Cuspidi C
    Recenti Prog Med; 2008 Apr; 99(4):191-9. PubMed ID: 18595632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical implications of trough to peak ratio].
    Hasebe N; Kikuchi K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():224-7. PubMed ID: 11028328
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive treatment: full 24 hour control and trough to peak ratio.
    Meredith PA
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):339-43. PubMed ID: 12497931
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect].
    Parati G; Omboni S; Mancia G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):345-8. PubMed ID: 12497932
    [No Abstract]   [Full Text] [Related]  

  • 15. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials?
    Staessen JA; Wang J
    J Nephrol; 2002; 15(4):422-7. PubMed ID: 12243374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of ongoing controlled clinical trials of hypertension treatment].
    Hernes KH
    Tidsskr Nor Laegeforen; 1996 Feb; 116(4):535. PubMed ID: 8644062
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic implications of recent megatrials: in favor of old drugs.
    Salvetti A; Salvetti G; Cipriano A; Virdis A; Ghiadoni L
    J Nephrol; 2007; 20 Suppl 12():S4-S11. PubMed ID: 18050142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How fast and how low blood pressure to be lowered in hypertensives?
    Arya SN; Ranjan P
    J Indian Med Assoc; 1997 Aug; 95(8):451-3. PubMed ID: 9492452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Benefits of antihypertensive treatment. How much damage does it really prevent?].
    Holzgreve H
    MMW Fortschr Med; 2006 Apr; 148(14):47, 49-50. PubMed ID: 16669282
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes from treatment. Clinical applications from recent trials.
    Howes LG
    Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.